Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Serina Therapeutics (SER) has shared an announcement.
Serina Therapeutics, Inc. has bolstered its executive team by appointing Dr. Srini Tenjarla as the new Senior Vice President of CMC & Formulation. With a rich background from Takeda Pharmaceuticals and prior experience at Shire Pharmaceuticals, Dr. Tenjarla brings a wealth of expertise in drug product development to oversee Serina’s expanding pipeline. His academic credentials include a Ph.D. in Pharmaceutical Sciences and a B.Sc. in Pharmacy, promising to enhance the company’s capacity in bringing new therapies to market.
Learn more about SER stock on TipRanks’ Stock Analysis page.
